The anticipated Super El Niño conditions, which are expected to last through a substantial portion of 2026 and into early 2027, have underscored this...
The company has received final observations from SEBI for its proposed IPO.
In April, Garuda had filed a confidential Draft Red Hearing Prospectus (DRHP) for...
In an interaction, he said the Indian smartphone market has undergone a structural transformation, with the average device replacement cycle extending from around nine...
The project will be developed on a land parcel admeasuring 9.33 acres being leased from the Delhi Development Authority (DDA). The multi-speciality hospital project...
The Boards of both companies approved the scheme of amalgamation on Wednesday. The transaction, which is subject to shareholder and regulatory approvals, will consolidate...
The device, called ε-µD, relies on screen-printed carbon electrodes embedded in a simple microfluidic chip and uses electrochemical impedance spectroscopy to detect bacterial growth...
The sale proceeds will be utilised to pare down outstanding debt of the promoter group, according to a statement.
Subsequent to the sale, the promoter...
With penetration still low and nearly 400 million citizens either uninsured or underinsured, the partnership aims to bridge India’s healthcare gap, the company said...
Total income rose 22.3% YoY to ₹501 crore, marking the company’s highest-ever quarterly revenue, while EBITDA climbed 28.9% to ₹141 crore, with margins at...
The company is planning 10 centres, including 2 super-speciality hospitals and 8 vision clinics across the Chennai.
Dr. GSK Velu called the launch a homecoming,...
